n(4)-acetylsulfamethoxazole has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hekster, CA; van der Kleijn, E; Vree, TB | 1 |
| Damsma, JE; Friesen, WT; Hafkenscheid, JC; Hekster, YA; van Dalen, R; Vree, TB | 1 |
2 other study(ies) available for n(4)-acetylsulfamethoxazole and Kidney Diseases
| Article | Year |
|---|---|
Significance of apparent half-lives of a metabolite with a higher elimination rate than its parent drug.
Topics: Diazepam; Glucuronates; Half-Life; Humans; Kidney Diseases; Metabolic Clearance Rate; Oxazepam; Pharmaceutical Preparations; Sulfamethoxazole | 1982 |
Renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole in patients with impaired kidney function.
Topics: Acetylation; Biotransformation; Chromatography, High Pressure Liquid; Creatinine; Humans; Kidney Diseases; Kinetics; Metabolic Clearance Rate; Sulfamethoxazole | 1981 |